Registration of share capital increase of 4,711,832 new B shares completed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH...
Year: 2021
AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular...
Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS--Novo Integrated Sciences, Inc. (OTCQB:NVOS) (OTCQB:NVOSD), a provider of multi-dimensional primary healthcare services and products in Canada and...
HARRIS Flex Upgrades to InterSystems IRIS for Health™
Technology migration expands interoperability and enhances patient care across 60 hospital systems throughout North America, Europe, and Middle East. CAMBRIDGE,...
LENSAR Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. O’Farrell
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq:LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions...
Senseonics Announces Initiation of European Commercial Efforts by Partner Ascensia Diabetes Care
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term,...
ConnectiveRx Announces Exclusive Partnership with Veradigm to Deliver High-Impact Point-of-Care Communications
Formation of new premium EHR network reaches more than 130 million patients, helps prescribers improve health outcomes WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx,...
Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC...
AiCuris Changes its Legal Form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG
Transition will support the Company in exploring additional opportunities for future growth AiCuris shareholders elect Helga Rübsamen-Schaeff, Sean Marett and...
Grapefruit USA, Inc. Announces Its Disruptive Hourglass(TM) Time Release THC+CBD Delivery Cream Is Now Available on Weedmaps Retail Website
LOS ANGELES and DESERT HOT SPRINGS, CA / ACCESSWIRE / February 1, 2021 / Grapefruit USA, Inc., (OTCQB:GPFT) ("Grapefruit" or...
Evotec CSO Cord Dohrmann Appointed to German Council of Science and Humanities
HAMBURG, GERMANY / ACCESSWIRE / February 1, 2021 / Evotec (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that...
Progress Update on MedMira’s COVID-19 Product Family
HALIFAX, Nova Scotia, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the development of a...
Haymarket Media Group Expands US Board as It Enters Its Next Phase of Rapid Growth
Haymarket Media Group bolsters its US Board, including the appointment of two national leaders in oncology and digital health technology,...
Hemogenyx Pharmaceuticals PLC Announces Publication of Prospectus
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN OR INTO ANY JURISDICTION WHERE...
Nationwide Medication Savings Leader Prescription Hope Introduces Work-from-Home Positions
STUART, FL / ACCESSWIRE / January 29, 2021 / Prescription Hope, one of the largest patient assistance program administrators in...
Novamind to Present at Canaccord Genuity Conference: “New Paradigms & Treatment Approaches in Mental Health”
Conference highlights industry leaders and innovators in the psychedelic therapy space and features Michael Pollan, author of New York Times...
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
SAN DIEGO, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and...
Turning Point Therapeutics Reports Updated Interim Data From Registrational Phase 2 Trident-1 Study of Repotrectinib in Patients With ROS1-Positive TKI-Naïve Non-Small Cell Lung Cancer
Phase 2 Confirmed Objective Response Rate is 93% (95% CI: 68-100); Pooled Phase 1/2 Confirmed Objective Response Rate is 91%...
Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis
Hamilton, Bermuda, January 29, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that...
Vivos Therapeutics Forms Clinical Advisory Board to Drive Further Growth of Next-Generation Obstructive Sleep Apnea Treatment Efforts
Internationally Recognized Medical and Dental Industry Veterans Will Work Closely with Vivos Management to Drive Further Commercial SuccessHIGHLANDS RANCH, Colo.,...